Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

As World Antibiotic Awareness Week aims to highlight the growing issue of antibiotic resistance, researchers at the University of Oxford have received funding to look at ways to improve the prescribing of antibiotics.

Image courtesy of Shutterstock

This is part of a larger investment of over £15.8 million into research to tackle into drug resistant infections, by the National Institute for Health Research (NIHR), the research arm of the NHS.

Sixteen studies have been funded as part of a call for more research into drug resistant infections, also known as antimicrobial resistance (AMR). Drug resistant infections present a major threat to the future of healthcare and by 2050 could result in 10 million avoidable deaths every year, from antibiotic resistant infections such as MRSA, sepsis and multi-drug-resistant mycobacterium tuberculosis.

Read more

Similar stories

Researchers develop machine learning algorithm to diagnose deep vein thrombosis

A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don’t have it.

COVID-19 recovery project nominated for HSJ award

The project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine is in the running for a prestigious honour at the Health Service Journal Awards 2021.

Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS

A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.

Blood bank storage can reduce ability of transfusions to treat anaemia

New research from Department of Physiology, Anatomy & Genetics (DPAG), in collaboration with NHS Blood and Transplant, has demonstrated that the process of storing blood in blood banks can negatively impact the function of red blood cells and consequently may reduce the effectiveness of blood transfusions, a treatment commonly used to combat anaemia.